683
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity

, , , , &
Pages 787-791 | Received 27 Mar 2014, Accepted 01 Jul 2014, Published online: 08 Sep 2014
 

Abstract

We studied procalcitonin (PCT) levels at hospital admittance and their association with aetiology and severity in patients with community-acquired pneumonia (CAP). Median PCT concentrations were higher in bacteraemic patients than in those without bacteraemia (6.11 μg/L vs 0.34 μg/L, p = 0.0002), in patients with non-bacteraemic pneumococcal aetiology than in those infected with other classic bacteria (1.18 vs 0.18, p = 0.038), and in patients with pneumococcal as compared with viral aetiology (2.43 vs 0.24, p = 0.017). When aetiology, bacteraemia and severity according to the pneumonia severity index (PSI) were included in logistic regression analyses with PCT > 0.5 as a dependent variable, the odds ratio (OR) for non-bacteraemic pneumococcal aetiology was 5.7 (p = 0.008) and 3.0 ( p = 0.1) for PSI 4–5. A separate analysis for bacteraemia and PSI 4–5 showed an OR of 17.5 (p = 0.008) and 2.7 (p = 0.092), respectively. In CAP patients, high PCT seems to be a good marker for invasive disease and pneumococcal aetiology. As a predictor of severity it appears to be less important.

Acknowledgments

The authors thank Dr Lars-Olof Hansson, Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden for contributing data regarding inflammatory markers.

Declaration of interest: The study was supported by grants from Karolinska Institutet. The funding source had no role in study design, data collection, data analysis or interpretation, or writing of the report. The authors declare that they have no conflicts of interest.

Notice of correction

The Early Online version of this article published online ahead of print on 8 Sep 2014 contained errors in .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.